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ReviewThe Potential of Muscle Stem Cells
daughter myoblasts both by biochemical and biologicalPatrick Seale,1,2 Atsushi Asakura,2
and Michael A. Rudnicki1,2,3 criteria (Seale and Rudnicki, 2000).
Skeletal muscle also contains a population of adult1 Department of Biology
McMaster University stem cells, so-called muscle-derived stem cells that ex-
hibit the ability to differentiate into a variety of cell types.Hamilton, Ontario L8S 4K1
2 Molecular Medicine Program Muscle-derived stem cells are enriched by fluores-
cence-activated cell sorting (FACS) of Hoechst-stainedOttawa Health Research Institute
Ottawa, Ontario K1H 8L6 dissociated muscle cells (Figure 2). Muscle-derived
stem cells represent a proportion of side populationCanada
(SP) cells, which actively exclude Hoechst 33342 dye
(Gussoni et al., 1999; Jackson et al., 1999). The efflux
of Hoechst dye in SP cells is mediated by the activitySkeletal muscle contains two types of stem cells: sat-
ellite cells, which function as myogenic precursors, of multidrug resistance (mdr)-type proteins on the cell
surface. The SP fraction, first identified in murine boneand a population of multipotent adult stem cells. Satel-
lite cells are believed to form a stable, self-renewing marrow, is highly enriched for long-term repopulating
hematopoietic stem cells (Goodell et al., 1997). The SPpool of stem cells in adult muscle where they function
in tissue growth and repair. An additional stem cell from skeletal muscle similarly contains stem cells capa-
ble of bone marrow reconstitution and myogenesis fol-population in adult muscle displays a remarkable ca-
pacity to differentiate into hematopoietic cells as well lowing systemic introduction into lethally irradiated
mice.as muscle following transplantation. This article dis-
cusses the characteristics and properties of these cell The discovery of multipotent adult stem cells in di-
verse tissues has raised many questions concerningpopulations, the relationship between them, and the
potential for stem cell-based muscle therapeutics. their normal role and function as well as their potential
utility for cell-mediated therapy. In this review, we sum-
marize our current understanding of the different stemIntroduction
The unexpected differentiation plasticity displayed by cells within muscle and discuss their utility for regenera-
tive medicine.stem cells from adult tissues has challenged the widely
held belief that tissue-specific cells are committed to
a developmental fate. By definition, a stem cell is not Muscle Satellite Cells
differentiated, displays a capacity for self-renewal Muscle satellite cells are born during the final wave of
throughout the lifetime of an organism, and has the embryonic myogenesis, first appearing in the limbs of
potential to give rise to a large number of differentiated mouse embryos at about 17.5 days postcoitum
progeny. Importantly, both muscle satellite cells and (Bischoff, 1994). Myoblasts derived from satellite cells
muscle-derived stem cells satisfy these criteria. Stem can be distinguished from embryonic and fetal myo-
cell plasticity reflects the range of differentiated cell blasts by morphological criteria, their capacity to differ-
types that a single cell can generate in response to entiate appropriately in the presence of the phorbol es-
different stimuli (reviewed by Blau et al., 2001). For in- ter TPA, and by a distinct fingerprint of expressed genes
stance, hematopoietic stem cells are multipotent in that (Figure 1; Beauchamp et al., 2000; Bischoff, 1994; De
they give rise to all of the differentiated cell types in Angelis et al., 1999). The developmental origin of satellite
blood. Satellite cells, by contrast, are unipotent, since cells appears to be separate from other myogenic pre-
they normally give rise to only one type of differentiated cursors that originate during embryonic and fetal life.
progeny, that is, myogenic precursor cells. Early studies suggested that the somitic mesoderm
Satellite cells define a unique lineage of myogenic gives rise to all myogenic lineages, including satellite
progenitors that arise late in development and are re- cells (Armand et al., 1983). However, De Angelis and
quired for postnatal muscle growth and repair (reviewed coworkers observed that embryonic blood vessels con-
by Bischoff, 1994; Seale and Rudnicki, 2000; Figure 1). tain a developmental source of satellite cell progenitors
They have classically been defined by strict morphologi- (De Angelis et al., 1999). Their work convincingly demon-
cal criteria as occupying grooves or depressions be- strates that dorsal aortic explants as well as limbs from
tween the basal lamina and sarcolemma of muscle fibers pax3/ and c-met/ embryos, which do not possess
(Mauro, 1961; Figure 1). However, they can now be de- migrating embryonic muscle precursors, give rise to col-
fined by gene expression profiles and in vivo function. onies of myogenic cells identical to satellite cell-derived
Satellite cells express specific genes such as m-Cadh- myoblasts. This study thus raised the intriguing possibil-
erin, CD34, and Pax7, and following activation, give rise ity that tissue-specific stem cell populations, such as
to large numbers of daughter myoblasts in addition to satellite cells in skeletal muscle, may develop from
repopulating the satellite cell pool (Beauchamp et al., multipotent precursors associated with the vascular
1999, 2000; Seale et al., 2000). Satellite cells thus repre- system.
sent committed stem cells, which are distinct from their Several studies have suggested that satellite cells are
not a homogeneous pool of committed myogenic stem
cells, but rather exist as a heterogeneous population3 E-mail: mrudnicki@ohri.ca
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muscles were suggested to function as a “reserve” pop-
ulation to be set aside as quiescent stem cells for mature
muscle (Schultz, 1996). A population of cells in muscle
has also recently been described which continues to
participate in myofiber repair following high doses of
radiation (Heslop et al., 2000). Together, these data sug-
gest that satellite cells are a heterogeneous class of
myogenic stem cells. However, whether these subpopu-
lations reflect the existence of distinct cell lineages or
dynamic cellular phenotypes remains to be determined.
Quiescent satellite cells are activated during normal
growth, by exercise, stretching, and injury, and in degen-
erative diseases such as muscular dystrophy. Activated
satellite cells enter the cell cycle and give rise to muscle
precursor cells (mpc), which undergo multiple rounds
of proliferation prior to terminal differentiation and fusion
with new or growing myofibers. Based on several lines
of evidence, hepatocyte growth factor (HGF), together
with its receptor, c-met, have emerged as important, if
not integral mediators, of satellite cell activation (Allen
et al., 1995; Anastasi et al., 1997; Tatsumi et al., 1998).
However, a physiological mechanism for the release of
HGF in response to myofiber damage or stress has yet
to be established. Other molecules implicated in the
activation or expansion of satellite cells during regenera-
tion include FGF-2, FGF-6, LIF, IL-6, IGF-1, and NO (re-
viewed by Seale and Rudnicki, 2000). What remains un-
clear is whether any of these different growth factors
impinge on the de novo formation of satellite cells, exert
effects at the level of satellite cell self-renewal, or func-
tion solely to stimulate expansion of the pool of replicat-
ing myoblasts.
Muscle growth (increase in fiber size) in response to
functional overload such as weight lifting is also medi-
ated at least in part by the recruitment of satellite cell
nuclei to myofibers as well as increased protein synthe-
sis (Rosenblatt et al., 1994). IGF-1 is implicated in myo-
fiber hypertrophy through induction of the calcineurin-
NFAT signaling pathway, which upregulates the activityFigure 1. Satellite Cells Are the Committed Myogenic Stem Cells of
Adult Muscle of GATA2 (Musaro et al., 1999, 2001; Semsarian et al.,
1999). Furthermore, calcineurin-NFAT activity promotes(A) Transmission electron micrograph of a satellite cell (SC) as identi-
fied by the plasma membrane (arrowheads) separating the satellite Myf5 expression in nonfusing myogenic “reserve” cells
cell from adjacent myofiber, the continuous basal lamina sur- from differentiated muscle cultures, suggesting that this
rounding the satellite cell and myofiber (arrows), and the heterochro- pathway may also target direct activation of Myf5 in
matic appearance of the nucleus. MN, myonucleus within fiber
satellite cells (Friday and Pavlath, 2001). Strikingly, adultnuclei.
mice lacking NFATC2 have small muscles, likely due to(B) Myf5-nlacZ is expressed in myonuclei in fresh (day 0) single
defects in nuclear accretion of myoblasts to growingmuscle fibers as well as activated satellite cells and myoblasts (day
3) derived from Myf5-nlacZ mice (Beauchamp et al., 2000). muscle fibers (Horsley et al., 2001). Importantly, these
studies imply that modulating IGF-1/NFAT signaling may
offer novel therapeutic approaches to prevent atrophy
and weakness in aging muscles.with different subpopulations exhibiting distinct bio-
chemical and biological properties. For example, satel-
lite cells are heterogeneous with respect to the expres- The Myogenic Regulatory Factors in Satellite Cells
The expression profile of the myogenic factors MyoD,sion of CD34 and Myf5-nlacZ, with a small proportion
of satellite cells expressing neither marker (Beauchamp Myf5, myogenin, and MRF4 in the satellite cell lineage
is analogous to the developmental program manifestedet al., 2000). It is possible that these putative satellite
cells expressing no myogenic markers are muscle- during embryonic myogenesis. Quiescent satellite cells
in vivo do not appear to express detectable levels ofderived stem cells that have been “trapped” in satellite
cell positions. In addition, there is a slowly dividing sub- any myogenic regulatory factor (MRF) (Cooper et al.,
1999; Cornelison and Wold, 1997; Smith et al., 1994). Thepopulation of myogenic progenitor cells that displays an
increased capacity for survival and expansion following presence of lacZ-expressing satellite cells in cultured
muscle fibers from Myf5-nlacZ mice, however, suggeststransplantation (Table 1; Beauchamp et al., 1999). Simi-
larly, slowly dividing satellite cells identified in growing the possibility that Myf5 is transcribed at low levels in
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Figure 2. Isolation of Adult Stem Cells by
FACS
(A) FACS fractionation of side population (SP)
cells from marrow and muscle allows the iso-
lation of adult stem cells on the basis of
Hoechst dye exclusion.
(B) FACS/Hoechst-purified SP (arrowheads)
from skeletal muscle together with primary
myoblasts (arrows) for size comparison. Note
the small size of muscle-derived SP (10 m
in diameter).
satellite cells (Beauchamp et al., 2000). Alternatively, upregulate either MyoD or Myf5 within 3 hr of experimen-
tally induced muscle injury prior to entering S phase atthe preparation of single muscle fibers may activate
quiescent satellite cells and induce transcription from about 30 hr postinjury and subsequent coexpression of
Myf5 and MyoD (Cooper et al., 1999; Cornelison andthe Myf5 locus. It is also conceivable that induction of
Myf5-nlacZ in satellite cells is unique to this particular Wold, 1997).
Adult mice lacking MyoD display marked deficits intargeted allele. Once activated, satellite cells rapidly
Table 1. Myogenic Cells and Stem Cells Used for Transplantation in Mice
Description Properties Reference
Myoblasts: determined primary Low rates of survival and therapeutic benefit Partridge, 2000
muscle cells and cell lines following transplantation.
mc13: clonal population of Adherent fraction of muscle-derived cells that engraft Lee et al., 2000
myogenic cells muscle efficiently upon transplantation.
Slowly dividing subpopulation of Small fraction of muscle-derived cells which survive Beauchamp et al., 1999
muscle-derived cells (in vitro) and persist following transplantation into muscle.
Neonatal primary myoblasts Give rise to satellite cells following intramuscular Heslop et al., 2001
transplantation.
Sca-1/CD34 muscle-derived Muscle-derived cells purified by FACS engraft Torrente et al., 2001
cells muscle following intraarterial injection.
Bone marrow SP cells FACS-enriched hematopoietic stem cells home to Gussoni et al., 1999
muscle and participate in myofiber formation
following systemic administration.
Muscle SP cells FACS-enriched cells engraft skeletal muscle and Gussoni et al., 1999
appear to give rise to satellite cells following bone
marrow transplantation.
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satellite cell function together with increased numbers
of satellite cells (Megeney et al., 1996). Consistent with
this observation, primary MyoD/myogenic cells exhibit
primitive characteristics and a marked reduction in dif-
ferentiation potential (Cornelison et al., 2000; Sabourin
et al., 1999). Expression of Myf5 alone may thus define
an intermediate developmental stage that facilitates sat-
ellite cell self-renewal.
Satellite Cells Are Myogenic Stem Cells
Satellite cells conform to the definition of a stem cell in
that they possess an inherent capacity for self-renewal
over multiple cycles of experimentally induced degener-
ation and regeneration, and give rise to daughter cells
that exhibit a large potential for expansion prior to termi-
nal differentiation. The absence of MRF expression in
quiescent satellite cells together with the expression of
specific markers including CD34, M-Cadherin, Msx1,
c-Met, and Pax7 further supports the assertion that sat-
ellite cells represent stem cells with identities distinct
from myoblasts (Beauchamp et al., 2000; Cornelison et
al., 2000; Cornelison and Wold, 1997; Seale et al., 2000;
Smith et al., 1994). Although activated satellite cells are
restricted to the development of determined muscle pre-
cursors in vivo, transdifferentiation of muscle precursors
to osteocytes and adipocytes has been observed follow-
Figure 3. Hypothesized Relationship between Adult and Tissue-ing exposure to different culture conditions, indicating
Specific Stem Cells
that the satellite cell lineage has maintained the capacity
According to this model, muscle-derived stem cells are the progeni-
to activate alternative developmental programs (Lee et tors of satellite cells and coexist as distinct stem cell tiers in some
al., 2000; Teboul et al., 1995). state of equilibrium within adult muscle.
The steady-state numbers of satellite cells remains
relatively unchanged between adulthood (2 months) and
old age (2 years) in mice, suggesting that a functional muscle-derived stem cells may represent the direct pro-
pool of stem cells is maintained throughout life (McGea- genitors of satellite cells (see Figure 3; Seale et al., 2000).
chie and Grounds, 1995). This observation is further
Multipotent Adult Stem Cellssupported by the stable nature of telomeres in satellite
Muscle satellite cells have been described as unipotentcells from young and old human muscles alike, sug-
stem cells responsible for the growth and repair of mus-gesting minimal cell turnover throughout adulthood (De-
cle. However, recent experiments have identified thecary et al., 1997). The loss of muscle mass which occurs
existence of adult stem cells in most if not all tissueswith aging is thus likely to reflect changes to the in vivo
that exhibit the ability to differentiate into many differentmicroenvironment of satellite cells required for efficient
cell types following transplantation.activation and differentiation of satellite cells.
Transplantation studies have demonstrated the abilityThe molecular mechanisms responsible for the self-
of bone marrow cells to give rise to myogenic cellsrenewal of satellite cells in vivo remain unknown. It is
during bouts of muscle regeneration. Ferrari and col-possible that asymmetric division of satellite cells gives
leagues performed a seminal study in which marrowrise to a committed myogenic progenitor and a repopu-
from mice carrying a -galactosidase transgene ex-lating “self” similar to developmental processes in the
pressed under the control of a muscle-specific promoterDrosophila and mammalian CNS (Jan and Jan, 1998).
was transplanted into immunodeficient mice (Ferrari et
To date, asymmetric localization of determination fac-
al., 1998). Following chemically induced muscle dam-
tors has not been reported in newly activated satel- age, small numbers of lacZ-stained nuclei were detected
lite cells. Alternatively, Myf5-expressing satellite cells, in regenerating muscle fibers. Similarly, Bittner et al.
which do not upregulate MyoD, may exist transiently (1999) demonstrated recruitment of donor-derived mar-
in regenerating muscle and function to replenish the row cells to skeletal and cardiac muscles of mdx (dys-
satellite cell pool (Sabourin et al., 1999). In addition, trophin-deficient) mice. In their experiments, donor male
determined MyoD:Myf5 muscle precursor cells or nuclei (detected by Y chromosome-specific fluores-
even terminally differentiated muscle may dedifferenti- cence in situ hybridization [FISH]) were also detected
ate to form satellite cells. Notably, Msx1, which is ex- in endothelial cells. Collectively, these studies indicate
pressed in satellite cells, can repress MRF activity in the capacity of marrow-derived cells to circulate, home
myogenic cells and has been suggested to induce dedif- to sites of muscle damage, and differentiate into myo-
ferentiation of cultured myotubes (Cornelison et al., genic and other lineages in response to the host tissue
environment.2000; Odelberg et al., 2000; Song et al., 1992). Lastly,
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To investigate whether hematopoietic stem cells have Pax3 and Pax7 in Myogenic Determination
the capacity to participate in muscle repair, fractionated Pax7 encodes a paired box-containing transcription fac-
marrow SP cells were introduced systemically into le- tor that belongs to a gene family implicated in the control
thally irradiated mdx (dystrophic) hosts. Significantly, of diverse developmental processes. Pax7 is expressed
transplantation of 2000–5000 marrow SP cells restored in quiescent and activated satellite cells and is required
dystrophin expression to about 4% of host muscle fibers for the specification of the muscle satellite cell lineage.
12 weeks after engraftment (Gussoni et al., 1999). More Pax7-deficient skeletal muscle is histologically indistin-
recently, however, transplantation of normal bone mar- guishable from wild-type muscle at birth; however, it is
row into irradiated mdx hosts efficiently repopulated completely devoid of muscle satellite cells (Seale et al.,
the marrow but restored dystrophin expression to an 2000). Significantly, Pax7-deficient muscle contains nor-
average of only 0.23% of fibers at various times following mal numbers of SP cells and a high level of hematopoi-
transplant (Ferrari et al., 2001). The poor level of muscle etic progenitor activity. Together, these results demon-
engraftment achieved in this study suggests inefficient strate that satellite cells and muscle-derived SP cells
recruitment and/or myogenic conversion of marrow represent distinct cell populations resident in skeletal
stem cells. muscle.
Similar experiments with fractionated muscle SP cells Extensive investigation into the role of Pax3, a paralog
indicate that adult skeletal muscle harbors multipotent of Pax7, in embryonic myogenesis has provided testable
stem cell activity. Introduction of muscle SP cells into hypotheses regarding the activity of Pax7 in adult mus-
irradiated mdx recipients reconstitutes the bone marrow cle. Splotch (Sp) mutant mice lacking functional Pax3
and contributes to regenerating muscle with donor- display impaired migration of somitic myogenic precur-
derived nuclei detected in 9% of recipient muscle fibers sors to developing limb buds (Bober et al., 1994; Borycki
(Gussoni et al., 1999). Importantly, in contrast to marrow- and Emerson, 1997). Furthermore, compound mutant
derived cells, muscle-derived stem cells apparently Sp/Myf5/ mice do not express MyoD in their somites,
gave rise to satellite cells in recently regenerated host suggesting that Myf5 and Pax3 function upstream of
fibers. Perhaps most strikingly, muscle-derived cells MyoD in myogenic determination (Tajbakhsh et al.,
were capable of long-term repopulation of marrow and 1997). Ectopic expression of Pax3 in mesodermal ex-
contributed to all major blood lineages 3 months follow- plants from avian embryos is sufficient to activate skele-
ing injection (Jackson et al., 1999). Taken together, these tal myogenesis (Maroto et al., 1997). Moreover, domi-
experiments demonstrate that muscle tissue contains nant repression of Pax3 target genes by constitutive
a population of multipotent stem cells that can be en- expression of a chimeric Pax3-Engrailed repressor do-
riched based on Hoechst dye exclusion. main fusion protein inhibits myogenesis in P19 em-
An analogous study revealed that neural stem cells bryonal carcinoma cells (Ridgeway and Skerjanc, 2001).
repopulate the bone marrow/blood system in lethally Collectively, these studies support a model by which
irradiated mouse recipients (Bjornson et al., 1999). Such Pax3 or Pax7 is required for the specification of stem
neural stem cells were previously thought to be re- cells directed toward the myogenic lineage in the em-
stricted in potential to the development of neurons, oli- bryo and adult, respectively.
godendrocytes, and astrocytes. Neural stem cells have
also been suggested to contribute to a very broad range
Muscle-Derived Stem Cells and the Ontogeny
of differentiated cell types following injection into mouse
of Satellite Cellsand chicken embryos (Clarke et al., 2000).
Based on several lines of evidence, it is hypothesizedThe plasticity of bone marrow cells has now been
that muscle-derived stem cells may represent progeni-clearly demonstrated in numerous reports. For instance,
tors for satellite cells in adult skeletal muscle. Thismarrow-derived cells can differentiate as microglia and
hypothesis is first supported by the muscle-forming ca-astroglia following bone marrow transplantation (Eglitis
pacity of muscle-derived stem cells following trans-and Mezey, 1997), give rise to differentiated neurons
plantation in mice (Gussoni et al., 1999). Furthermore,following intravenous delivery into mice (Brazelton et
transplanted muscle-derived stem cells are found in sat-al., 2000; Mezey et al., 2000), as well as contribute to
ellite cell positions within host muscle fibers (Gussonibone, cartilage, and lung tissues (Pereira et al., 1998).
et al., 1999). Moreover, the increased numbers of hema-Furthermore, hematopoietic stem cells exhibit the po-
topoietic progenitors in Pax7-deficient muscle suggeststential to differentiate into hepatocytes as well as cardio-
that Pax7 stimulates the development of satellite cellsmyocytes following transplantation (Alison et al., 2000;
by restricting alternative developmental pathways (i.e.,Bittner et al., 1999; Jackson et al., 2001; Lagasse et al.,
hematopoiesis) in muscle-derived stem cells (Seale et2000; Orlic et al., 2001). Evidence for the pluripotentiality
al., 2000).of single stem cells is supported by experiments in which
However, an alternative hypothesis for considerationlimiting dilutions of hematopoietic stem cells were used
is that muscle-derived stem cells may possess an intrin-to achieve long-term bone marrow reconstitution and
sic capacity to differentiate directly into myogenic cells,engraftment of epithelial tissues in mice (Krause et al.,
altogether bypassing the satellite cell compartment. For2001). Taken together, the results highlighted here sug-
example, sonic hedgehog (Shh) or other molecules ingest that adult stem cells maintain the capacity to acti-
regenerating muscle may induce MRF expression withinvate diverse developmental programs following expo-
stem cells to activate myogenesis (Borycki et al., 1999).sure to appropriate environmental cues. Therefore,
These mechanisms are not mutually exclusive, and mus-these studies challenge the widely held view that adult
cle regeneration could be manifested by both satellitetissues possess only specialized stem cells that are pre-
determined to give rise to a particular cell type. cells and independent recruitment of adult stem cells.
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An important outstanding issue concerns the location due to continuous regeneration as in MD implies that
the development of satellite cells may be temporallyof muscle-derived stem cells within skeletal muscle. The
notion that satellite cells account for the “multipotent” restricted rather than being continuous throughout adult
life. Alternatively, dystrophin-deficient myofibers maystem cell activity in muscle has been discounted by
the observation that Pax7-deficient muscle is devoid of display defects in the recruitment of satellite cells. Re-
gardless, the depletion of satellite cells in MD suggestssatellite cells but contains muscle-derived stem cells. It
is conceivable that the vascular-associated satellite cell that engraftment of wild-type (dystrophin) satellite cells
into dystrophic muscles would provide an effectiveprogenitors identified in the embryo (De Angelis et al.,
1999) persist in close association with blood vessels as therapy.
muscle-derived stem cells in adult muscle. According to
this hypothesis, muscle-derived stem cell and satellite cell Myoblast/Stem Cell Transplantation
populations would coexist as distinct stem cell tiers in In the past, transplantation of cultured myoblasts has
some state of equilibrium within adult muscle (Figure 3). been largely ineffectual due to the rapid loss of trans-
Direct proof of a precursor/product relationship be- planted cells and their inability to migrate significantly
tween muscle-derived stem cells and satellite cells is from the site of injection (Partridge, 2000). However, a
lacking, and several questions remain outstanding. Can study conducted by Huard’s group identified a clonal
muscle-derived stem cells give rise to satellite cells? If population of muscle progenitor cells (mc13 cells) iso-
so, what is the flux between muscle-derived stem cell lated on the basis of differential adhesion that efficiently
and satellite cell compartments? It is possible that mus- participates in muscle regeneration (Table 1; Lee et al.,
cle-derived stem cells only contribute small numbers of 2000). Muscle progenitors have also been isolated by
nuclei to regenerating muscle but do not normally give flow cytometry on the basis of CD34 and Sca-1 (stem cell
rise to determined myoblasts or satellite cells under antigen-1) expression that appear to engraft dystrophic
physiological conditions in vivo. mouse muscle following intraarterial injection (Torrente
Is the birth of satellite cells continuous throughout et al., 2001). In addition, recent studies with newborn
adult life or is their formation developmentally re- primary myoblast cultures indicate that they have the
stricted? Do muscle-derived stem cells represent a ho- capacity to form satellite cells following transplantation
mogeneous pool of stem cells or alternatively, represent (Heslop et al., 2001). However, whether any of these
a heterogeneous pool with distinct subsets of potential cultured cells represent true stem cell pools remains to
and plasticity? For instance, it remains to be determined be established. Nevertheless, continuous myogenic cell
whether a given cell with hematopoietic activity from lines may prove useful as a source of myogenic progeni-
the marrow or muscle SP is also capable of myogenic tors for direct or systemic transplantation (Table 1).
differentiation. These important problems are experi- The use of bona fide stem cells in transplantation
mentally tractable, and therefore should be resolved in regimes for the treatment of degenerative diseases in-
the near future. Nonetheless, the presence of plastic cluding muscular dystrophy clearly holds much promise.
adult stem cells in many tissues has cleared the way for While it is feasible to deliver stem cells intravenously,
the development of strategies to exploit the properties of significant problems exist in attaining useful levels of
these cells in clinical settings. stable engraftment into host muscle. Stem cell therapies
may be improved by exposing the cells to combinations
of growth factors or small molecules to direct or facilitateMuscular Dystrophy
differentiation. Therefore, the molecular signals and en-Muscular dystrophy defines a collection of over 20 inher-
vironmental cues which regulate quiescence and differ-ited disorders affecting on the order of 1/3500 live births
entiation of muscle stem cells must be identified andworldwide on a yearly basis (Ozawa et al., 1998). About
carefully characterized as the first step in the ongoing2/3 of muscular dystrophies are classified as Duchenne
efforts to employ these cells for the purposes of regener-muscular dystrophy (DMD) or its milder allelic form,
ative medicine.Becker’s muscular dystrophy (BMD), arising from muta-
In an alternative approach, the introduction of devel-tions in the X-linked dystrophin gene. Dystrophin and
opmental control genes into adult stem cells may be aits associated proteins function to link the intracellular
useful strategy to direct their differentiation. For exam-actin cytoskeleton of muscle to laminins in the extracel-
ple, forced expression of Pax7 with viral vectors in iso-lular matrix, thereby protecting myofibers from contrac-
lated SP-derived stem cells may promote the formationtion-induced damage (Figure 4; Bonilla et al., 1988).
of satellite cell progenitors with an increased capacityOther forms of muscular dystrophy arise from defective
to regenerate muscle. Detailed analysis of the potentialinteractions between integrin 71 on muscle cells with
of muscle-derived stem cells ectopically expressing de-extracellular laminins (Figure 4; Gullberg et al., 1999).
velopmental control genes will elucidate the utility ofThus, integrin/laminin and dystrophin/laminin interac-
such an approach. Studies addressing the efficiency oftions are required for maintaining the structural integrity
ex vivo viral transduction to stem cells are also requiredof muscle fibers.
to determine whether genetic information can be effec-Damage to the muscle sarcolemma due to loss of
tively introduced into damaged tissue via stem cells.dystrophin complexes results in the continued activa-
tion of resident satellite cells. Repeated cycles of degen-
eration and regeneration in the skeletal muscles of DMD Alternatives to Myoblast/Stem Cell Transplant
To date, myogenic stem cell and myoblast transplanta-patients ensue, eventually exhausting the replicative ca-
pacity of satellite cells (Schultz and Jaryszak, 1985; tion have not attained a practical level of success for
use in human patients. A recent study by Burkin et al.Webster and Blau, 1990). The depletion of satellite cells
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Figure 4. Therapeutic Possibilities for Duchenne Muscular Dystrophy
(A) Intravenous delivery or direct intramuscular injection of muscle-derived stem cells and myogenic cell lines to provide a source of dystrophin
myogenic cells in diseased muscles.
(B) Adenoviral-mediated gene transfer of dystrophin or utrophin directly into muscle.
(C) Administration of Deflazacort (corticosteroid) slows the progression of muscle pathology in DMD.
(D) A schematic representation of the dystrophin/glycoprotein complex and the integrin/laminin-mediated attachment of muscle cells to the
surrounding extracellular matrix. Upregulation of utrophin or integrin 7 compensates for the functional loss of dystrophin.
(2001) suggests that pharmacological modulation of promising results in dystrophic animals (Figure 4; Gilbert
et al., 1998; Howell et al., 1998; Wakefield et al., 2000;basal lamina component expression may provide a
novel approach to treat muscle disease (Figure 4). Nota- Wang et al., 2000). Further studies to optimize transduc-
tion, vector design, and immune tolerance will be re-bly, increased expression of the integrin 7 chain signifi-
cantly improves muscle pathology, longevity, and mobil- quired to permit the use of these technologies success-
fully in human patients (reviewed by Hartigan-O’Connority in dystrophin/utrophin compound mutant animals.
This result suggests that increased binding of integrin and Chamberlain, 2000).
71 in muscle cells to laminin in the extracellular matrix
can partially rescue structural muscle weakness caused
Perspectivesby defects in the dystrophin protein complex. Similarly,
The identification of multipotent adult stem cells in manyincreased expression of utrophin, a homolog of dys-
tissues including muscle has stimulated wide interesttrophin expressed highly at neuromuscular junctions,
in stem cell biology. However, it is clear that there remaincan alleviate muscle pathology by compensating for the
huge gaps in our understanding of the molecular mecha-lack of dystrophin (Rafael et al., 1998; Tinsley et al.,
nisms regulating adult stem cell development and differ-1998).
entiation. Lessons learned from the study of organ andDeflazacort, a steroid hormone, has beneficial effects
cell differentiation in the embryo will certainly be valu-in dystrophic animals and human subjects, acting to
able guides in understanding the biology of adult stemimprove muscle strength and reduce the extent of car-
cells.diac pathology (Figure 4; Biggar et al., 2001; Reitter,
The advent of gene array and proteomic technologies1995; Skrabek and Anderson, 2001). Its mechanism of
together with the sequencing of genomes from humansaction remains unclear; however, a recent report sug-
and experimental organisms will provide tremendousgests that it acts by increasing laminin expression and
resources for stem cell research in the “genomic era.”promoting myoblast proliferation (Anderson et al., 2000).
New technological approaches make it possible to iden-Finally, the use of adenovirus and adeno-associated
tify genes and proteins expressed in small numbers ofvirus to deliver functional dystrophin, utrophin, or corre-
sponding “minigenes” to diseased muscle has yielded cells or even individual cells. Therefore, the generation of
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